Drug Database
DO

donepezil (E 2022 / TK023 / TK 023)

✓ Approved

Eisai Co., Ltd. · ACHE · 小分子

什么是 donepezil?

donepezil 是一种小分子,由Eisai Co., Ltd.研发。该药已获批,用于治疗相关适应症,给药途径:Transdermal。

药物档案

商品名E 2022, TK023, TK 023
公司Eisai Co., Ltd.
药物类别小分子
分子靶点ACHE
给药途径Transdermal
状态Approved

作用机制

分子靶点

donepezil 作用于 1 个分子靶点:

ACHEacetylcholinesterase (Cartwright blood group) (N-ACHE, ACEE)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

donepezil 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Nervous system disordersDementia Alzheimer's typePhase I

相关研究文献

PubMedBMC neurology2026-11-19

Therapeutic regimen for AD-derived MCI: the effect of sodium oligomannate (GV-971) combined with donepezil on patients' cognitive function and hippocampal atrophy rate.

Jiao Fucheng F, Li Yuhua Y, Zhang Lina L, Fang Caixia C et al.

To investigate the clinical efficacy of sodium oligomannate (GV-971) combined with donepezil in the treatment of patients with mild cognitive impairment (MCI) in Alzheimer's disease (AD). This non-randomized, open-label, retrospective analytic study included 100 patients with AD-derived MCI who were treated in our hospital between May 2023 and May 2024, and were divided into two groups according to the different treatment modalities recorded in the electronic medical record system: 44 cases in the control group (donepezil), and 56 cases in the observation group (sodium oligomannate (GV-971) combined with donepezil). Cognitive function, biochemical markers (homocysteine (Hcy), S100 calcium binding protein B (S100β), neuron-specific enolase (NSE)), serum intestinal flora metabolic markers (phenylalanine (Phe), short-chain fatty acids (SCFA), γ-aminobutyric acid (GABA), acetylcholine (Ach)), hippocampal volume, and adverse effects were collected and compared between the two groups, and adverse reactions were recorded. After treatment, the comparison of various scores of cognitive function, Hcy, S100β, NSE, Phe, SCFA, GABA, and Ach between the patients in the observation group and the control group showed statistically significant differences (P<0.05); after treatment, the comparison of left hippocampal volume, right hippocampal volume, and total volume between the observation group and the control group did not show any statistically significant difference (P>0.05). In contrast, the calculated hippocampal atrophy rate-derived from the percentage change relative to baseline volume-was significantly lower in the observation group than in the control group (P < 0.05). Regarding safety, the total incidence of adverse reactions was 10.71% (6/56) in the observation group versus 9.09% (4/44) in the control group, with no statistically significant difference between the two groups (P > 0.05). The combination of sodium oligomannate (GV-971) and donepezil was associated with more favorable changes in cognitive function, neuronal injury biomarkers, serum markers of gut microbiota metabolism, and a slower observed rate of hippocampal atrophy in patients with AD-derived MCI. These associations do not imply causation, and the combination regimen did not significantly increase adverse reactions in this cohort.

PMID 43052811
阅读全文 →
PubMedJournal of nanobiotechnology2026-11-19

Wearable microneedle-delivered homotypic exosomes sensitize ferroptosis for triple-negative breast cancer therapy.

Xiao Qiyao Q, Wang Yiyi Y, Yang Cheng C, Yan Ge G et al.

Triple-negative breast cancer (TNBC) is clinically intractable due to its aggressiveness and lack of targeted therapies. While inducing ferroptosis via RSL3 shows promise, its efficacy is limited by tumor redox adaptation and systemic toxicity. Mono-target approaches are insufficient against TNBC's adaptive survival mechanisms. To overcome this, we developed a bioinspired wearable platform, R@CTE-M. This platform co-delivers RSL3, a glutathione peroxidase 4 (GPX4) inhibitor, and bioactive endogenous Tripterygium wilfordii-derived exosomal miRNAs (TE-miRs) using engineered Tripterygium wilfordii-derived exosomes (TExos) camouflaged with homologous 4T1 cancer cell membranes. This construct is integrated into a 3D-printed porous microneedle patch for localized transdermal delivery. The homologous membrane enables 4T1 tumor-targeted delivery. R@CTE-M markedly inhibited tumor growth and showed a favorable preliminary biocompatibility profile in the 4T1 tumor-bearing mouse model. Mechanistically, TE-miRs disrupt redox homeostasis, activate JNK/FoxO-mediated apoptosis, and downregulate SLC7A11, thereby sensitizing cells to RSL3-triggered ferroptosis. This coordinated multi-pathway attack enhances the ferroptotic response, overcoming intrinsic resistance and reducing systemic toxicity. R@CTE-M represents a novel, wearable exosome-based multi-target therapy, offering a transformative and translatable strategy for TNBC treatment.

PMID 43053092
阅读全文 →
PubMedScientific data2026-11-19

A multi-center annotated oral cytology dataset for AI-assisted early detection of oral squamous cell carcinoma.

Jain Garima G, Patil Abhijeet A, Goel Poonam P, Pati Sanghamitra S et al.

Oral squamous cell carcinoma is a major public health burden, particularly in regions with limited access to specialist pathology services. Oral brush cytology provides a minimally invasive approach for screening and early assessment, but the development of automated analysis methods requires well-annotated, multi-source datasets. We present a multicenter oral cytology dataset collected from tertiary medical centers in India. The dataset includes Papanicolaou- and May-Grünwald-Giemsa-stained whole-slide images, associated patient- and slide-level metadata, high-resolution image patches, and expert-verified nucleus-level annotations in QuPath-compatible GeoJSON format. The annotations support computational tasks including nucleus segmentation, instance segmentation, and cytological category classification. Dataset-level validation checks are provided to document file completeness, metadata consistency, annotation integrity, patch-to-slide linkage, and reuse readiness. The dataset is intended to facilitate development and benchmarking of computational pathology methods for oral cytology analysis.

PMID 43052319
阅读全文 →
PubMedClinical transplantation2026-11-19

Innovations in Psychosocial Care Management for Acute Alcohol-Related Hepatitis Transplant Recipients: Feasibility and Acceptability of a Motivational Interviewing Video Reinforcement Intervention.

DiMartini Andrea F AF, Amrhein Paul C PC, Lee Mary M, Behari Jaideep J et al.

Acute Alcohol-related hepatitis (AAH) liver transplant (LT) recipients are often transplanted urgently prior to addiction counseling. Interventions to promote maintenance of abstinence are needed for this population. We developed and piloted the feasibility and acceptability of an innovative intervention for AAH patients; a motivational interviewing (MI) video reinforcement intervention to strengthen motivation for abstinence and paired it with a transdermal alcohol monitoring biosensor (TAS). MI is an established technique for eliciting reasons to stop drinking (i.e., change talk). Ten AAH LT recipients participated in a 4-month pilot of our video intervention. Participants underwent a video-taped MI interview from which selected clips were archived on an iPad as a personalized video library of their change talk. They viewed videos weekly, wore the TAS, and were queried about alcohol use with a standardized instrument. At intake participants expressed poor efforts to change behavior but felt confident of not drinking. At study end qualitative data showed participants felt repeated video viewing strengthened motivation by reminding them of their reasons to stay sober keeping those reasons uppermost in their mind. They noted repeated viewing of their videos reinforced their intentions. However, some felt that seeing themselves was distracting or disturbing. Participants identified potential intervention format and delivery improvements. While the emotional intensity of their LT experience could be compelling, for some revisiting this time was distressing. Intervention refinements to further enhance acceptability and feasibility while minimizing distress are underway with plans for subsequent efficacy evaluation in a randomized controlled trial.

PMID 43052554
阅读全文 →
PubMedJournal of cell science2026-11-19

AlphaFold-Multimer reveals diverse cyclin-CDK substrate docking interactions.

Willich Sarah S, Kapadia Nitin N, Nurse Paul P

Cyclin-dependent kinases (CDKs) control eukaryotic cell-cycle progression by phosphorylating specific substrates with substrate recognition often involving cyclin-specific docking interactions. However, in minimal cell cycle control systems driven by a single cyclin-CDK complex, how docking interactions contribute to the differential timing of substrate phosphorylation remains unclear. Here, we used AlphaFold-Multimer to systematically predict interactions between the fission yeast mitotic cyclin-CDK fusion Cdc13-L-Cdc2 and its known in vivo CDK substrates. We found that many substrates are predicted to interact with the cyclin hydrophobic patch, and have identified a previously uncharacterised docking motif, [FVIPWGLAM](x)xER[LMV] (ERL motif), with features consistent with an atypical RxL motif. We show that ERL motifs can functionally substitute for canonical RxL motifs to promote phosphorylation of a model CDK substrate by Cdc13-Cdc2, while the S-phase cyclin-CDK Cig2-Cdc2 was found to preferentially phosphorylate substrates containing canonical RxL motifs. Interestingly, Cdc13-L-Cdc2 was not predicted to bind DNA replication substrates preferentially over mitotic substrates, suggesting that other mechanisms underlie the temporal ordering of CDK substrate phosphorylation. These results reveal that cyclin-CDK-substrate interactions are more diverse than previously thought.

PMID 43053692
阅读全文 →
PubMedNature communications2026-11-19

Structural basis of TACO1 function in mitochondrial translation elongation.

Singh Vivek V, Gallenstein Raven R, Wanes George G, Shiriaev Dmitri Igorevich DI et al.

Protein synthesis depends on specialized regulatory factors to overcome difficult-to-translate sequences during elongation that cause ribosomal stalling. In human mitochondria, this function is carried out by TACO1 (Translation activator of COX1). Here, we report the cryo-electron microscopy structure of human TACO1 bound to the mitoribosome, revealing its mechanistic role as a dedicated elongation regulator. Unlike the prokaryotic elongation factor EF-P and the eukaryotic eIF5A, which bind the ribosomal E site and stabilize P-site tRNA to facilitate peptide bond formation, TACO1 adopts a distinct strategy. It binds near the A site, closely interacting with the Sarcin Ricin loop and the L7/L12 stalk, similar to general translation elongation factors, such as EF-Tumt and mtEF-G1mt, and contacts the A-site tRNA. Using AlphaFold analysis and molecular dynamics simulations, we further show how a series of conformational changes allow its N-terminal domain to reorient and transiently engage with the A-site tRNA via a conserved and functionally critical basic amino acid patch. The bacterial homolog of TACO1, namely YebC2, shares the structural features required for its function. Overall, we present an evolutionarily conserved mechanism employed by TACO1 to enhance mitochondrial translation efficiency.

PMID 43052283
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多donepezil